This information was published on 2025-11-17T12:08:43 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2468956 (IR 1801711) |
| (220) |
07 Jun 2024
|
| (300) |
US, 07 Dec 2023, 98304066
|
| (511) (510) |
Class 5
Pharmaceutical preparations and substances, namely, polypeptides, antibodies, and antibody derivatives, for use in the treatment of autoimmune disorders and conditions, and cancer. |
| (540) | ADAPTIR |
| (550) | Word |
| (730) |
Aptevo Research and Development LLC
|
| (750) |
Spruson & Ferguson
|
Find out more about publications on the About page.